Maintain BNY at benchmark weight with disciplined bilateral tripwire architecture pending technical confirmation
Three-analyst convergence on Hold as correct baseline is unusual and worth weighting heavily. Aggressive Buy thesis is empirically invalid (0-for-3 on alpha capture at technical breakdowns, 1.5-1.7:1 risk-reward collapses to ~1:1 when probability-weighted with 50% continuation-down, 35% modest bounce, 15% bull case). BNY's forward PE of 14.59x sits above JPM, BAC, and GS despite slower top-line growth. Structural floor intact at $134.77 200 SMA with 14% ROE, 29.4% net margins, $62T AUC franchise, and $4.5B annual buybacks providing fundamental support. No asymmetric macro catalyst with 96% no-cut pricing fully discounted. Time-boxed patience to Q3 2026 earnings mid-October binary catalyst.
| Position | Action |
|---|---|
| Price in $142-145 zone | Aggressive accumulation where risk/reward becomes genuinely asymmetric |
| Current technical deterioration (MACD -1.89 expanding, RSI 29, lower Bollinger Band break) | Maintain existing exposure; do not trim despite 9% pullback from record Q2 2026 EPS of $2.45 |
| Weekly close below $134 | Downgrade to Underweight |
BNY's 8% pullback is a gift, not a breakdown—the stock trades 11% above its 200 SMA, just delivered record Q2 2026 EPS of $2.45, and offers a 14.59x forward PE on 22% EPS growth with three concurrent growth catalysts (AI cross-sell, $4.54B annual buybacks, digital asset optionality) creating asymmetric long-term upside.
| Indicator | Value | Signal |
|---|---|---|
| close_50_sma | 159.14 | bearish |
| close_200_sma | 134.77 | neutral |
| close_10_ema | 155.36 | bearish |
| macd | -1.89 | bearish |
| macdh | -1.44 | bearish |
| rsi | 29.16 | neutral |
| boll_lb | 150.18 | bearish |
| vwma | 157.14 | bearish |
Support: 149.21 · 150.18 · 134.77 | Resistance: 155.36 · 157.14 · 159.14 · 159.55 · 168.93
BNY is undergoing a sharp short-term correction within a still-intact long-term uptrend. Price has broken below the 50 SMA (-6%), the 10 EMA (-3.8%), and the lower Bollinger Band (150.18), confirming bearish momentum is building with no exhaustion yet. RSI is oversold at 29.16, creating bounce risk, but VWMA at 157.14 represents overhead cost-basis resistance that any rally must overcome. The 200 SMA at 134.77 is the critical structural bull/bear divider — a break would change the entire thesis. Volume on the sell-off (5–6M vs. ~2.5–3M average) confirms institutional distribution. The base case is a reflexive 1–3 session bounce to 153–157 before either basing or testing lower. HOLD is recommended for existing longs; new entries require MACD histogram contraction and reclaim of the 10 EMA at 155.36.
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Volume-confirmed reclaim of 10 EMA at $155.36
Then: Initiate fresh capital
BNY is a fee-based franchise with asset-manager economics, not a traditional commercial bank. Net margins of 29.41% far exceed typical bank margins of 15-22%.
↩ rebuts: “The bear's framework is stuck in 1995 commercial banking logic and misses BNY's structural fee-based model.”
EV: +5.7% to +10.4% (target $165 vs entry $149.51-$148) · concedes: Lost Kazia Therapeutics ADR mandate to JPMorgan (acknowledged as the bear's strongest card); Bear's technical report admitted: 'this is a correction within a larger advance — not a confirmed breakdown'
BNY is in a confirmed downtrend with institutional distribution, broken technical structure, and no margin of safety at a premium multiple—the bull case is already priced in, leaving asymmetric downside risk.
EV: -$15 to -$20 (target $145-142 from $149.51 entry, with $135 (200 SMA) as structural downside) · concedes: Structural uptrend intact at 200 SMA; Fee-based business model with 29.4% net margin and 40% operating margin is legitimate; Macro setup is genuinely bullish (96% odds no Fed cuts, 8% recession probability)
→ vs conservative: Technical damage (broken 50-day SMA, MACD at minus 1.89, RSI at 29, distribution volume of 5-6 million shares on Sep 15 and 17) signals positioning reset, not fundamental deterioration; short-term tape in isolation is not an investment thesis
→ vs conservative: 14.6x forward PE above JPM, BAC, and GS ignores structural superiority of fee-based franchise vs. leveraged balance sheet model; BNY operates a fee compounder, not a rate bet
→ vs neutral: Valuation concern is overblown; PEG of 0.66x on 29.4% net margin fee-based franchise is a bargain vs. SaaS at 30x with 15% growth
→ vs neutral: Forward growth narrative (AI-driven expense leverage + cross-sell monetization) will shift consensus from 'rate beneficiary' to 'AI productivity story' and expand multiple materially; waiting for confirmation means buying 20% higher
→ vs conservative: Confirmation-first mentality systematically turns high-probability mean-reversion setups into missed opportunities; waiting for MACD contraction before buying means chasing 155 again
Market Cap
$101.44 billion
PE Ratio (TTM)
17.88x
Forward PE
14.59x
PEG Ratio
1.14
Price to Book
2.54x
Dividend Yield
1.48%
Beta
1.05
52-Week Range
$103.11 – $165.84
50-Day Moving Average
$159.26
200-Day Moving Average
$135.52
Revenue (TTM)
$21.42 billion
Net Income (TTM)
$6.02 billion
Profit Margin
29.41%
Operating Margin
40.05%
ROE
14.12%
ROA
1.26%
Diluted EPS (TTM)
$8.36
Forward EPS
$10.25
Diluted EPS Q2 2026
$2.45
Diluted EPS 2025
$7.40
Diluted EPS 2024
$5.80
Diluted EPS 2023
$4.00
Diluted EPS 2022
$2.90
Diluted EPS 2021
$2.90
Total Assets Q2 2026
$561.517 billion
Cash & Equivalents Q2 2026
$187.04 billion
Total Investments Q2 2026
$174.943 billion
Net Loans Q2 2026
$101.024 billion
Goodwill & Intangibles Q2 2026
$22.254 billion
Total Equity Q2 2026
$45.319 billion
Stockholders' Equity Q2 2026
$44.78 billion
Long-Term Debt Q2 2026
$32.757 billion
Tangible Book Value
$22.53 billion
Revenue 2025
$19.759 billion
Revenue 2024
$18.258 billion
Revenue 2023
$17.344 billion
Revenue 2021
$16.186 billion
Net Income 2025
$5.549 billion
Net Income 2024
$4.530 billion
Net Income 2023
$3.302 billion
Net Income 2022
$2.556 billion
Net Income 2021
$2.556 billion
Net Interest Income 2025
$4.944 billion
Net Interest Income 2024
$4.312 billion
NII Q1 2026
$1.37 billion
Operating Cash Flow 2025
$6.73 billion
Free Cash Flow 2025
$5.177 billion
CapEx 2025
$1.553 billion
Share Repurchases 2025
$4.54 billion
Dividends Paid 2025
$1.69 billion
Shares Outstanding (basic avg, Q2 2026)
~686 million
Revenue Q2 2026
$5.336 billion
Revenue Q1 2026
$5.106 billion
Net Income Q2 2026
$1.632 billion
Net Income Q1 2026
$1.632 billion
Total Capitalization
$77.5 billion
Common Equity
$39.4 billion
Preferred Equity
$5.3 billion
Goodwill
$16.7 billion
Net Loans to Total Assets
18%
Cash + Investments to Total Assets
65%
Strengths
Concerns
BNY Mellon is the world's largest custodian bank with a high-quality, fee-driven business model that delivered record Q2 2026 EPS of $2.45 and 18.6% YoY revenue growth, supported by 29.4% net margins and aggressive $4.54B annual buybacks. The valuation is fair to slightly rich at 17.88x trailing PE / 14.59x forward PE, particularly given the stock's proximity to its 52-week high. For traders, the best entry point is on a pullback to the 50-day MA (~$159) or 200-day MA (~$135), rather than chasing at current levels near $166.
Macro: Prediction markets pricing 96% probability of no Fed rate cuts through 2026 with short rates at 3.9% and 10-year yields near 5%, indicating a higher-for-longer rate regime. U.S. recession probability at 8% (down 4pp week-over-week) reflects soft-landing consensus. Global backdrop benign with UK recession at 12% and Japan at 4%. Digital asset market showing elevated volatility with Bitcoin above $86K and $800M in crypto liquidations, signaling institutionalization trends that support custody demand.